Company Search:
Advanced Search
Sponsored Links
MorphoSys AG Company Snapshot
MorphoSys AG operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MorphoSys AG with three other miscellaneous service companies in Europe: Ergomed PLC of the United Kingdom (2016 sales of £39.23 million [US$52.31 million] of which 67% was Clinical Research Service), Basilea Pharmaceutica Limited of Switzerland (65.04 million Swiss Francs [US$65.56 million] of which 100% was Pharmaceutical Products), and Cellectis SA which is based in France (51.01 million Euro [US$60.01 million] of which 105% was Therapeutics).

Sales Analysis. During the year ended December of 2016, sales at MorphoSys AG were 49.74 million Euro (US$58.52 million). This is a sharp decrease of 53.2% versus 2015, when the company's sales were 106.22 million Euro. Contributing to the drop in overall sales was the 99.0% decline in Proprietary Development, from 59.94 million Euro to 621,000.00 Euro. . However, these declines were partially offset by the increase in sales of Partnered Discovery (up 6.1% to 49.12 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
MorphoSys AG
  Stock Performance Chart for MorphoSys AG
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 80.52
(Figures in Euro)
1 Week 0.7%   13 Weeks 5.2%  
4 Weeks 22.6%   52 Weeks 79.1%  
MorphoSys AG Key Data:
  Ticker: MOR Country: Germany
  Exchanges: DUS FRA OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 49,743,515
(Year Ending Jan 2017).
Employees: 345
  Currency: Euro Market Cap: 2,336,735,974
  Fiscal Yr Ends: December Shares Outstanding: 29,020,566
  Share Type: Stammaktie Closely Held Shares: 684,942
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.